AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
aTyr Pharma, Inc.
$4.94
-$25.42 (-83.73%)
Previous Close
$5.37
Day Range
$4.32$5.30
Year Range
$4.07$44.40
Market Cap
12.11M
AVG Volume
78.76K
Trailing/Forward PE
-0.2/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: ATYR
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.
Video analysis: ATYR
All videosNo video analysis for this stock yet. Request one from our team.
News: ATYR
Similar companies
-
ALX Oncology Holdings Inc.
ALXO
·
NASDAQ
Compare
-
CAMP4 Therapeutics Corporation
CAMP
·
NASDAQ
Compare
-
Metagenomi, Inc. Common Stock
MGX
·
NASDAQ
Compare
-
Unicycive Therapeutics, Inc.
UNCY
·
NASDAQ
Compare
-
Relmada Therapeutics, Inc.
RLMD
·
NASDAQ
Compare
-
Acrivon Therapeutics, Inc. Common Stock
ACRV
·
NASDAQ
Compare